Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has so far infected 762 million people with over 6.9 million deaths worldwide. Broad-spectrum viral inhibitors that block the initial stages of infection by reducing virus binding and
